Mirugen Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $2.93M

  • Investors
  • 6

Mirugen General Information

Description

Developer of cell reprogramming therapies designed to restore sight. The company utilizes a discovery platform that integrates sequencing data, bioinformatics, and high-throughput screening to identify transcription factors for cell conversion, enabling healthcare professionals to treat patients with retinitis pigmentosa by regenerating light-sensing photoreceptors and restoring vision.

Contact Information

Website
www.mirugen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 9
  • 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Drug Discovery
Corporate Office
  • Level 9
  • 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia

Mirugen Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mirugen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 13-Aug-2025 $2.93M Completed Pre-Clinical Trials
2. Accelerator/Incubator 23-Dec-2024 Completed Pre-Clinical Trials
1. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
To view Mirugen’s complete valuation and funding history, request access »

Mirugen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mirugen Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandon Capital Venture Capital Minority
Genesis Pre-Seed Fund Venture Capital Minority
Tin Alley Ventures Venture Capital Minority
ANDHealth Accelerator/Incubator
Brandon Biocatalyst Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Mirugen FAQs

  • When was Mirugen founded?

    Mirugen was founded in 2022.

  • Where is Mirugen headquartered?

    Mirugen is headquartered in Melbourne, Australia.

  • What is the size of Mirugen?

    Mirugen has 3 total employees.

  • What industry is Mirugen in?

    Mirugen’s primary industry is Biotechnology.

  • Is Mirugen a private or public company?

    Mirugen is a Private company.

  • What is Mirugen’s current revenue?

    The current revenue for Mirugen is .

  • How much funding has Mirugen raised over time?

    Mirugen has raised $4.85M.

  • Who are Mirugen’s investors?

    Brandon Capital, Genesis Pre-Seed Fund, Tin Alley Ventures, ANDHealth, and Brandon Biocatalyst are 5 of 6 investors who have invested in Mirugen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process